Background: Adenomyosis is an estrogen-dependent gynecologic condition that can cause
pain symptoms, heavy menstrual bleeding, and infertility. Several treatments, including …

Estrogens and progestogens act on female reproductive tissues in opposite ways. As they
counteract each other actions, the correct balance between these two classes of hormones …

First described nearly two centuries ago, adenomyosis remains to this day a huge clinical
challenge due to its complex symptomology, enigmatic pathogenesis, and pathophysiology …

Objective To compare the efficacy and safety of dienogest with combined oral contraceptives
(COCs) for treating adenomyosis‐associated symptoms. Methods This was a randomized …

Objective To evaluate the effect of a 10 mg per day 12 week treatment of ulipristal acetate
(UPA) on abnormal uterine bleeding due to adenomyosis. Design A double-blind phase 2 …

Objective To assess the efficacy and safety of percutaneous image-guided cryoablation of
adenomyomas Material and Methods Five symptomatic women who wanted to preserve …

This study aimed to identify differentially expressed genes (DEGs) and molecular pathways
in eutopic endometrial stromal cells (EuESCs) from adenomyosis (AM) patients and to …

Adenomyosis is a debilitating gynecological disease of the uterus with no medicinal cure.
The tissue injury and repair hypothesis for adenomyosis suggests that uterine …

More than 10 years following the publication of “The General Rules for Clinical Management
of Endometriosis: The second edition” in January 2010, the longawaited third edition has …

Levonorgestrel-releasing intrauterine system (LNG-IUS) relieves dysmenorrhea and heavy
menstrual bleeding (HMB) in adenomyosis. However, its efficacy on health-related quality of …